CELC
Celcuity Sees Bright Future Ahead as Gedatolisib Nears FDA Approval
Celcuity, a biotechnology company focused on developing innovative treatments for various types of cancer, has made significant strides in its mission to revolutionize the field of oncology. In a recent conference call, Celcuity's leadership team presented the company's Q4 2025 financial results and business update, highlighting